These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10025668)
1. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. Faust J; Lacey DL; Hunt P; Burgess TL; Scully S; Van G; Eli A; Qian Y; Shalhoub V J Cell Biochem; 1999 Jan; 72(1):67-80. PubMed ID: 10025668 [TBL] [Abstract][Full Text] [Related]
2. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328 [TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507 [TBL] [Abstract][Full Text] [Related]
4. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. Connor JR; Dodds RA; James IE; Gowen M J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635 [TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw. Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862 [TBL] [Abstract][Full Text] [Related]
6. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467 [TBL] [Abstract][Full Text] [Related]
7. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts. Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680 [TBL] [Abstract][Full Text] [Related]
8. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279 [TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Neale SD; Smith R; Wass JA; Athanasou NA Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353 [TBL] [Abstract][Full Text] [Related]
10. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Purton LE; Lee MY; Torok-Storb B Blood; 1996 Mar; 87(5):1802-8. PubMed ID: 8634426 [TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499 [TBL] [Abstract][Full Text] [Related]
12. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654 [TBL] [Abstract][Full Text] [Related]
13. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation. Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436 [TBL] [Abstract][Full Text] [Related]
14. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021 [TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H; Härkönen PL; Väänänen HK; Hentunen TA J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [TBL] [Abstract][Full Text] [Related]
16. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Lee SK; Goldring SR; Lorenzo JA Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679 [TBL] [Abstract][Full Text] [Related]
17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046 [TBL] [Abstract][Full Text] [Related]